本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

142.85
-0.8500-0.59%
成交量:9.68萬
成交額:1,382.08萬
市值:92.44億
市盈率:138.69
高:143.65
開:143.09
低:140.44
收:143.70
52周最高:160.81
52周最低:58.91
股本:6,470.83萬
流通股本:6,316.60萬
量比:0.77
換手率:0.15%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:10.98
市盈率(LYR):-69.68

資料載入中...

2023/07/05

重要事件披露

Form 8-K - Current report
2023/07/04

重要事件披露

Form 8-K - Current report
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/10

重要事件披露

8-K - Current report
2023/03/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/06

重要事件披露

8-K - Current report
2023/01/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals